Charlotte Korst’s Post

We are excited to provide updated clinical safety and efficacy data from 7 transfusion-dependent beta thalassemia patients treated with renizgamglogene autogedtemcel (reni-cel) in the Phase 1/2 EdiThal clinical trial at European Hematology Association (EHA) annual congress. Treated patients had early and robust increases of total hemoglobin (Hb) and fetal hemoglobin, with total Hb rising to or above the transfusion independence threshold of 9.0 g/dL. All patients have been transfusion free for a range of 4.1 to 12.8 months after receiving the last red blood cell transfusion at 0.5–2.2 months post-reni-cel infusion. Reni-cel was well-tolerated and continues to demonstrate a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant. #BetaThalassemia #Biotechnology #Cas12a #CellTherapy #ClinicalTrials #CRISPR #EHA #GeneEditing #Hematology

Do carve out time in your busy schedule to meet Jennell and learn about RBC health biomarkers.

HaemaLogiX Ltd Chief Scientific Officer Dr Rosanne Dunn explains the key highlights of the abstract that was recently published in the European Hematology Association (EHA)’s official open access journal, HemaSphere Journal. Dr Dunn highlights that the data have shown that 100% of amyloidosis patient bone marrow plasma cells express either LMA or KMA. It is also highlighted that LMA and KMA define treatment-resistant, disease-causing plasma cells – in keeping with our published KappaMab Phase 2b clinical results which have also shown that our immunotherapies can deplete these persistent aberrant cells without affecting normal immune cells. Watch the full video below from Dr Dunn on the key highlights of this published data. For more details on this pre-clinical data and its publication, visit our website via this link: https://bit.ly/4b1QgNg

NEW #Thalassemia Sessions from #ASH23🩸 💬 In this session, leading experts Maria Domenica Cappellini & Kevin Kuo discuss exciting updates in #thalassemia presented at the 2023 ASH Annual Meeting and Exposition The experts cover several topics, including the promise of novel #genetherapies, ongoing #clinicaltrials in the field, and the value of #precisionmedicine 🔬 Take a look 👉 https://lnkd.in/e2-JsM7Y #HemOnc #MPNsm American Society of Hematology

Today we are working at conference EHA-KCS Hematology Tutorial on Recent Advances in Lymphoid and Myeloid Malignancies

Hematology focuses on treating disorders of the blood and is a large part of our practice and the patients we treat at FCS. Over the past several days, scientific abstracts from early and late-phase research submitted by FCS hematologists and medical oncologists have been presented at the American Society of Hematology 65th Annual Meeting and Exposition. Among the numerous studies featuring research conducted by FCS physicians, FCS president and managing physician Lucio N. Gordan, MD was first author of a comparative study of first-line treatment for patients newly diagnosed with multiple myeloma. Read about these breaking discoveries: https://lnkd.in/e-8cK3t3

How can your laboratory help reduce unnecessary complications for newly diagnosed Multiple Myeloma patients? Find out how from Prof. Guy Pratt who discusses how your laboratory can help guide blood test requesting and appropriate hematology referral. Download our case studies from hospitals in the United Kingdom, United States and Spain by here: https://hubs.li/Q02phTNn0

Unlock the secrets of hematology staining techniques with our latest blog post on the Wright-Giemsa stain! Perfect for laboratory professionals and students, this guide provides step-by-step instructions to help you achieve precise and accurate results 🔬🎨 Dive into the details here: https://bit.ly/3ycvOvL #WrightGiemsa #LabTutorial #HardyDiagnostics

👉 Discover the Latest Clinical Case: A 53-year-old patient diagnosed with 𝐇𝐚𝐢𝐫𝐲 𝐂𝐞𝐥𝐥 𝐋𝐞𝐮𝐤𝐞𝐦𝐢𝐚 (HCL). See how our Yumizen hematology analyzer helped identify key markers and guide the right approach. 🔹Read on website: https://lnkd.in/eJK52mz9 #HairyCellLeukemia #Leukemia #ClinialLab #MedicalLab #Hematology

Say goodbye to traditional diagnostic methods and hello to the revolutionary PRP Tube Plasma Gel. Our state-of-the-art product is designed to make your diagnostic process faster, easier and more accurate than ever before. With its unique gel formulation, PRP Tube Plasma Gel quickly and efficiently separates plasma from whole blood, allowing for easy sample collection and analysis. That means you get the results you need in less time, with less hassle and more confidence in the accuracy of your results.  PRP Tube Plasma Gel is also incredibly versatile, with a wide range of applications in fields such as hematology, oncology and transfusion medicine. Whether you work in a hospital, clinic or research lab, our plasma gels are the perfect tool for your diagnostic needs. So why wait? Upgrade your diagnostic capabilities today with PRP Tube Plasma Gel. With its superior performance, ease of use, and versatility, it's the smart choice for healthcare professionals who need optimal performance. Try it for yourself and see how it impacts your diagnostic procedures! Would love to have you as our partner!!! #mansonprp #laboratoryinstrument #centrifuge #plateletrichplasma  #prptherapy #prpfacial #prptubes #prptube #prpmicroneedling  #prp #prpfacelift #prptreatment #prphair #centrifugalmachine #labmedicalcentrifugemachine #highspeedcentrifuge